Literature DB >> 24158910

TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.

Gopi Krishna Singamsetty1, Sravanthi Malempati, Srichandana Bhogadhi, Ravinder Kondreddy, Suresh Govatati, Naveen Kumar Tangudu, Sowdamani Govatati, Anil Kumar kuraganti, Manjula Bhanoori, Kondaiah Kassetty.   

Abstract

The objective of the present study was to investigate the association between TP53 gene single nucleotide polymorphisms (SNPs) and colorectal cancer (CRC) predisposition in south Indian population and to evaluate the role of TP53 expression in the pathophysiology of CRC. A genetic association study was conducted in 103 CRC cases and 107 controls of south Indian origin. We genotyped ten selected TP53 SNPs by polymerase chain reaction-sequencing analysis. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D') for pairwise linkage disequilibrium (LD) were assessed by Haploview Software. In addition, to better understand the role of TP53 in the pathophysiology of CRC, the expression pattern was evaluated in analogous tumor and normal tissues from 23 CRC patients by Western blot analysis. The frequencies of Pro72Pro (P = 0.0033) genotype and Ser47/Pro72 (P = 0.00171) haplotype were significantly higher in patients as compared to controls. Strong LD was observed between codon 47 and 72 in cases (D' = 0.32) as compared to controls (D' = 0.21). The polymorphism was not observe at the remaining eight SNPs loci analyzed. Furthermore, increased TP53 expression was observed in tumor tissue than in analogous normal tissue of CRC patients. Interestingly, advanced stage tumors showed more elevated TP53 expression compared to early stage tumors. In conclusion, the TP53 Pro72Pro genotype and Ser47/Pro72 haplotype has an increased risk for CRC predisposition in south Indian population. In addition, elevated TP53 expression appears to be useful prognostic marker for CRC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158910     DOI: 10.1007/s13277-013-1305-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

1.  p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.

Authors:  G Lanza; I Maestri; A Dubini; R Gafa; A Santini; S Ferretti; L Cavazzini
Journal:  Am J Clin Pathol       Date:  1996-05       Impact factor: 2.493

2.  Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.

Authors:  Chiara Perfumo; Luigina Bonelli; Paola Menichini; Alberto Inga; Viviana Gismondi; Enrico Ciferri; Pierluigi Percivale; Giovanna Bianchi Scarrà; Sabina Nasti; Gilberto Fronza; Liliana Varesco
Journal:  Digestion       Date:  2007-03-20       Impact factor: 3.216

3.  Prognostic value of p53 genetic changes in colorectal cancer.

Authors:  U Kressner; M Inganäs; S Byding; I Blikstad; L Påhlman; B Glimelius; G Lindmark
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

4.  The codon 47 polymorphism in p53 is functionally significant.

Authors:  Xiaoxian Li; Patrick Dumont; Anthony Della Pietra; Cory Shetler; Maureen E Murphy
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

Review 5.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

6.  Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.

Authors:  E Felley-Bosco; A Weston; H M Cawley; W P Bennett; C C Harris
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

7.  Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population.

Authors:  Zhong-Zheng Zhu; Ai-Zhong Wang; Hang-Ruo Jia; Xia-Xiang Jin; Xiang-Lei He; Li-Fang Hou; Guanshan Zhu
Journal:  Jpn J Clin Oncol       Date:  2007-05       Impact factor: 3.019

8.  P53 germ line haplotypes associated with increased risk for colorectal cancer.

Authors:  A Själander; R Birgander; L Athlin; R Stenling; J Rutegård; L Beckman; G Beckman
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

9.  Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?

Authors:  Xiang-Lin Tan; Alexandra Nieters; Michael Hoffmeister; Lars Beckmann; Hermann Brenner; Jenny Chang-Claude
Journal:  Pharmacogenet Genomics       Date:  2007-08       Impact factor: 2.089

Review 10.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

View more
  7 in total

1.  TP53 Codon 72 Polymorphism and the Risk of Colorectal Cancer in an Azerbaijani Population.

Authors:  Vugar Yagublu; Bayram Bayramov; Melek Yuce; Hazi Aslanov
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

Review 2.  Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.

Authors:  Zahra Montazeri; Evropi Theodoratou; Christine Nyiraneza; Maria Timofeeva; Wanjing Chen; Victoria Svinti; Shanya Sivakumaran; Gillian Gresham; Laura Cubitt; Luis Carvajal-Carmona; Monica M Bertagnolli; Ann G Zauber; Ian Tomlinson; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Julian Little
Journal:  Int J Epidemiol       Date:  2015-10-07       Impact factor: 7.196

3.  Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability.

Authors:  Suresh Govatati; Sravanthi Malempati; Bulle Saradamma; Dasi Divyamaanasa; B Prathap Naidu; Pallaval Veera Bramhachari; Nagesh Narayana; Sisinthy Shivaji; Manjula Bhanoori; Raghava Rao Tamanam; Pasupuleti Sreenivasa Rao; Varadacharyulu Nallanchakravarthula
Journal:  Tumour Biol       Date:  2016-02-04

4.  Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.

Authors:  Suresh Govatati; Gopi Krishna Singamsetty; Nayudu Nallabelli; Sravanthi Malempati; Pasupuleti Sreenivasa Rao; Venkata Kranthi Kumar Madamchetty; Sowdamani Govatati; Rudramadevi Kanapuram; Nagesh Narayana; Manjula Bhanoori; Kondaiah Kassetty; Varadacharyulu Nallanchakravarthula
Journal:  Tumour Biol       Date:  2014-08-22

5.  The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.

Authors:  Xin Tian; Shundong Dai; Jing Sun; Shenyi Jiang; Youhong Jiang
Journal:  Oncotarget       Date:  2017-01-03

6.  Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis.

Authors:  Pei-Zhen Han; De-Hong Cao; Xue-Ling Zhang; Zheng-Ju Ren; Qiang Wei
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.

Authors:  Zhiyong Dong; Longzhi Zheng; Weimin Liu; Cunchuan Wang
Journal:  Cancer Manag Res       Date:  2018-05-25       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.